| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 5K8EAX0G53 |
| InChI Key | SNKZJIOFVMKAOJ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C3H9NO3S |
| Molecular Weight | 139.18 |
| AlogP | -0.78 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 80.39 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 8.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Ligand-gated ion channel
GABA-A receptor
|
- | 300 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | 18 | |
|
Membrane receptor
Family C G protein-coupled receptor
Small molecule receptor (family C GPCR)
Neurotransmitter receptor (family C GPCR)
GABA-B receptor
|
- | 2000-30000 | - | - | - | |
|
Membrane receptor
|
- | 2000-30000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Alzheimer Disease | 3 | D000544 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 1457 |
| ChEMBL | CHEMBL149082 |
| DrugBank | DB06527 |
| EPA CompTox | DTXSID80190352 |
| FDA SRS | 5K8EAX0G53 |
| KEGG | C03349 |
| PDB | A20 |
| PubChem | 1646 |
| SureChEMBL | SCHEMBL26759 |
| ZINC | ZINC000001529636 |